Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cetuximab Hepatocellular Carcinoma	Sanofi	P2	B (61)
Chimeric Antigen Receptor Modified T Cells Infusion Lymphoma	Chinese PLA General Hospital	P2	B (61)
CIS-DIAMMINEDICHLOROPLATINUM II Angioimmunoblastic T-Cell Lymphoma	Ou Bai, MD/PHD	P2	B (61)
CIS-DIAMMINEDICHLOROPLATINUM II Digestive System Cancer	National Cancer Institute (NCI)	P2	B (61)
CIS-DIAMMINEDICHLOROPLATINUM II Neoplastic Meningitis	Guangzhou Medical University	P2	B (61)
CLEMASTIN Relapsing-Remitting Multiple Sclerosis	University of California, San Francisco	P2	B (61)
Clofarabine Childhood Acute Myeloid Leukemia	Princess Maxima Center for Pediatric Oncology	P2	B (61)
Clofarabine T-Cell Non-Hodgkin Lymphoma	M.D. Anderson Cancer Center	P2	B (61)
CPX101 Obesity Disorder	Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.	P2	B (61)
Crizotinib Refractory Malignant Neoplasm	Massachusetts General Hospital	P2	B (61)
Cyclophosphamide Colon Carcinoma	Essen Biotech	P2	B (61)
Cyclophosphamide Ewing Sarcoma	Essen Biotech	P2	B (61)
Cyclophosphamide Gastroesophageal Cancer	Diwakar Davar	P2	B (61)
Cyclophosphamide Pancreatic Ductal Adenocarcinoma	City of Hope Medical Center	P2	B (61)
Cyclophosphamide Exocrine Pancreatic Carcinoma	Essen Biotech	P2	B (61)
Cyclophosphamide Li-Fraumeni Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (61)
Cyclosporin A Hematopoietic And Lymphoid System Neoplasm	Fred Hutchinson Cancer Center	P2	B (61)
Cyclosporin A Myelofibrosis	City of Hope Medical Center	P2	B (61)
Cytarabine Classic Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P2	B (61)
dd01 Metabolic Dysfunction-Associated Steatotic Liver Disease	Neuraly, Inc.	P2	B (61)
Dexasone Glioblastoma	City of Hope Medical Center	P2	B (61)
Dexasone High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	University of Washington	P2	B (61)
Docetaxel Esophageal Cancer	Laekna Limited	P2	B (61)
Docetaxel Melanoma	NuCana plc	P2	B (61)
ds-5141b Duchenne Muscular Dystrophy	Daiichi Sankyo Co., Ltd.	P2	B (61)

Showing 1376 to 1400 of 13,155 assets

PreviousPage 56 of 527Next